FDA Inspection
Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma ServicesLyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services – FDA Inspection, Apr 24, 2015
Record Details
This FDA Inspection record concerns Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services, with an inspection on April 24, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 24, 2015
- Product Type
- Drugs
View Company Profile
ID · fa6b0351-f7a7-4729-bead-18279f848829
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 925848
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2026 | Not classified | New England District Office | Drug Quality Assurance |
| May 24, 2024 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| September 27, 2023 | OAI | New England District Office | |
| December 7, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 15, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
- FDA Inspection 1321518 - 2026-06-10
- FDA Inspection 1239754 - 2024-05-24
- FDA Inspection 1218916 - 2023-09-27
- FDA Inspection 1074079 - 2018-12-07
- FDA Inspection 1003136 - 2017-02-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.